Advertisement
Home Tags Psoriasis

Tag: Psoriasis

The benefits of ixekizumab in the treatment of psoriasis extend to 60 weeks

Ixekizumab Efficacious for Psoriasis Over 60 Weeks

Four in five patients saw at least a 75 percent improvement in symptoms
Genetic variants have been identified in psoriasis patients that correlate with anti-tumor necrosis factor-α treatment response

Genetic Variants ID Treatment Response in Psoriasis

Ten SNPs presented that correlate with treatment responses to anti-TNF-α agents
Psoriasis may be linked to excess weight and type 2 diabetes

Research Finds Link Between Psoriasis, Obesity, T2DM

A genetic link is one theory for the possible association, researchers say
For patients with psoriasis

Ustekinumab More Effective Than TNF-α Inhibitors in Psoriasis

Ustekinumab more effective than three tumor necrosis factor-α-inhibitors at six, 12 months
Psoriasis patients may face a higher risk of an abdominal aortic aneurysm

Abdominal Aortic Aneurysm Odds Up for Patients With Psoriasis

Those with severe psoriasis 67 percent more likely to develop an AAA
The incidence of psoriatic arthritis is 2.7 cases per 100 psoriasis patients

Incidence of Psoriatic Arthritis 2.7/100 Psoriasis Patients

Variables linked to PsA development include severe psoriasis, low level of education, retinoid use
The U.S. Food and Drug Administration has approved its second-ever "biosimilar" drug

FDA Approves Inflectra as ‘Biosimilar’ to Remicade

For adults with Crohn's, rheumatoid arthritis, or psoriasis
For patients undergoing total hip arthroplasty

Psoriasis Does Not Worsen Total Hip Arthroplasty Outcomes

WOMAC OA Index scores for pain or function did not differ for patients with psoriasis, osteoarthritis
For patients with psoriasis

Anti-TNF Treatment Ups ANA Positivity in Psoriasis

Increased antinuclear antibody positivity, but no change in PASI-75 response rates
As the amount of psoriasis increases

More Severe Psoriasis Equals More Vascular Inflammation

Relationship held after accounting for other cardiovascular disease risk factors